12/04/2026
BinomLabs for Biochemistry Labs | AI Affinity Prediction & Lower Wet-Lab Costs
A protein-protein platform for your biochemistry lab, integrating predictive software into your workflows. Get a free software consultation now.
Direct e-mail: [email protected]
Additional info: https://binomlabs.com/free_pilot
Pilot Project Example download: https://drive.google.com/file/d/1OAkDP2KX0_o_QOhJp1fpHG494kcIt8EE/view?usp=sharing
This video explains how BinomLabs can be used as an AI decision-support platform for biochemistry labs and biopharmaceutical research. The presentation focuses on affinity-related forecasting, reduction of unnecessary experiments, cost-aware lab planning, and stronger alignment between calculated and experimental data. It is especially relevant for teams working in molecular interaction studies, protein stability, drug discovery, and experimental optimization.
BinomLabs helps experimental laboratories reduce the cost and volume of biochemical testing by predicting the most informative experimental conditions before wet-lab work begins. Instead of testing a large number of possible variants, buffers, temperatures, or molecular combinations, researchers can first receive a forecast of which conditions are most promising, and then validate only the best candidates experimentally.
This creates a very practical advantage for academic laboratories. In our completed proof of concept with proteins and Förster Resonance Energy Transfer, the original plan required ten experiments, but after using the predictive forecast, only three experiments were needed. That means a reduction of about seventy percent in wet-lab runs.
Why is this important? Because every experimental run costs money, instrument time, consumables, and valuable researcher effort.
For example, Differential Scanning Fluorimetry may cost about one hundred fifty dollars for ten runs, but with prediction-guided selection that can drop to about forty-five dollars
Differential Scanning Calorimetry may require four hundred to eleven hundred dollars for ten runs, but with preliminary forecasting this can fall to roughly one hundred twenty to three hundred thirty dollars.
Mass Photometry can drop from about four hundred to five hundred dollars down to only one hundred twenty to one hundred fifty dollars.
Dynamic Light Scattering can fall from roughly four hundred to five hundred eighty dollars down to about one hundred twenty to one hundred seventy-four dollars.
High-Performance Size-Exclusion Chromatography can be reduced from about five hundred dollars to around one hundred fifty dollars
Fourier-Transform Infrared Microscopy can decrease from more than one thousand dollars to about three hundred dollars. Capillary Isoelectric Focusing can fall from nearly one thousand dollars to less than three hundred dollars.
But the value of BinomLabs is not only in reducing direct assay cost. The platform also helps preserve expensive purified protein, reduce the use of fluorescent labels and reagents, shorten instrument booking time, and save researchers from spending days on low-value trial-and-error screening.
So the key benefit is simple: BinomLabs transforms a broad and expensive experimental search into a smaller, more focused validation stage. Researchers no longer need to test everything. They can test only the most promising conditions first. This makes biochemical research faster, cheaper, and more efficient, while still keeping experimental confirmation at the center of the workflow.
For academic laboratories, this means better use of limited grant budgets, better use of scarce protein samples, and faster progress toward publishable results.
